Literature DB >> 1324962

Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180.

G J Giudice1, D J Emery, L A Diaz.   

Abstract

Bullous pemphigoid (BP) is an autoimmune skin disease that is characterized by the presence of subepidermal blisters resulting from a disruption of the adhesive interactions between basal keratinocytes and the cutaneous basement membrane. Autoantibodies from patients suffering from this disorder recognize two epidermal antigens, BP180 and BP230, both of which have been localized to the hemidesmosome, a transmembrane structure of stratified, squamous epithelia that functions in cell-matrix adhesion. In the present study we report the primary structural analysis of BP180 based on the sequence of a series of overlapping cDNA clones encompassing 4,669 bases of the BP180 transcript. A polymerase chain reaction-based protocol was used to confirm the contiguity of the cDNA segments. This cloned portion of the BP180 transcript was found to contain one long open reading frame (ORF) 4.596 bases in length. This ORF encodes a polypeptide of 155,000 Daltons with an isoelectric point of 9.7. The carboxy-terminal half of BP180, a stretch of 916 amino acids, consists of 15 collagen domains of variable length (15 to 242 amino acids) that are separated from one another by short stretches of non-collagen sequences. Located 76 amino acids upstream of the collagenous region is a putative transmembrane domain, a structural feature that distinguishes BP180 from all of the well-characterized members of the collagen family. This membrane-spanning domain is predicted to function as a signal-anchor sequence, directing the C-terminal collagenous segment of this protein to the exterior of the cell. The putative intracellular domain is highly basic with an isoelectric point of 10.37. This molecular analysis predicts that the BP180 antigen is an integral membrane protein of the hemidesmosome that contains a long extracellular collagenous tail. This combination of structural features suggests that BP180 may function as a cell-matrix adhesion molecule, with the collagenous region acting as a potential site of interaction with basement membrane components. Autoantibody-mediated disruption of such an adhesive interaction may play a critical role in the development of sub-epidermal blisters in BP patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324962     DOI: 10.1111/1523-1747.ep12616580

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  77 in total

1.  The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome.

Authors:  S B Hopkinson; J C Jones
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes.

Authors:  J Koster; S van Wilpe; I Kuikman; S H M Litjens; A Sonnenberg
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

Review 3.  [Bullous autoimmune dermatoses. 2: Pathogenesis].

Authors:  M Hertl; G Schuler
Journal:  Hautarzt       Date:  2002-04       Impact factor: 0.751

4.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

5.  Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.

Authors:  F Van den Bergh; S L Eliason; G J Giudice
Journal:  Matrix Biol       Date:  2010-10-26       Impact factor: 11.583

Review 6.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Specificity of binding of the plectin actin-binding domain to beta4 integrin.

Authors:  Sandy H M Litjens; Jan Koster; Ingrid Kuikman; Sandra van Wilpe; Jose M de Pereda; Arnoud Sonnenberg
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

8.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.